ScripPaxlovid Approval Adds To Japan’s Oral Antiviral Arsenal Japan’s Ministry of health, Labour and Welfare issued an expedited emergency approval on 10 February for Pfizer Inc. ’s oral antiviral Paxlovi
Pink SheetThe US FDA’s Center for Drug Evaluation and Research didn’t turn in just a near-record high number of new molecular entity and novel therapeutic biologic approvals in 2021. The annual approvals class
ScripFollowing its late 2019 merger with Aevi Genomic Medicine, Inc. , Cerecor Inc. is taking a new name – Avalo Therapeutics – and revising its therapeutic focus, having divested a pair of central nerv
Pink SheetSerious concerns about manufacturing quality extended the US Food and Drug Administration’s fast-track review of Prometic Biotherapeutics Inc.’s designated orphan drug, Ryplazim (plasminogen, human-